Wide Swings in COVID-19 Vaccine Acceptance Across Indian Cohorts
India’s COVID-19 vaccination experience did not follow a single public pattern. A systematic review and meta-analysis of 26 studies found substantial variation in vaccine acceptance and vaccine hesitancy across settings, with the strongest signals coming from healthcare workers and the general population, but with marked inconsistency from study to study.
The review was designed to quantify how often people in India were willing to receive a COVID-19 vaccine and how often they were reluctant or unwilling. That question mattered during a public health campaign built on speed, scale, and repeated messaging. Acceptance and hesitancy are not abstract social attitudes in a pandemic; they shape uptake, cluster by geography and occupation, and influence how quickly a vaccination drive can translate into population-level protection.
How the Evidence Base Was Built
Investigators followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards and searched PubMed, Scopus, and DOAJ between May 1, 2024, and May 30, 2024. The search strategy used four core terms: “COVID-19,” “vaccine hesitancy,” “vaccine acceptance,” and “India.” After screening, 26 articles remained for analysis.
Study quality was assessed with the JBI Checklist for cross-sectional studies, a sensible choice for this evidence base because the included literature was observational rather than interventional. Pooled prevalence estimates were calculated with a random-effects model and 95% confidence intervals, reflecting the expectation that attitudes toward vaccination would vary across populations, regions, and time periods. Stata Now 18 SE was used for the statistical analysis.
The populations were unevenly distributed. Fourteen studies focused on healthcare workers, seven on the general population, two on pregnant women, and one each on school children, parents, and socioeconomically disadvantaged people. That spread matters because vaccine attitudes are often shaped by professional exposure, trust in institutions, perceived infection risk, and access to reliable information. A clinician working in a hospital corridor does not encounter the same decision environment as a parent in the community or a pregnant patient weighing fetal safety concerns.
Acceptance Was Similar in Two Major Groups, But the Spread Was Huge
Among the included studies, the highest reported vaccine acceptance reached 92.74% in healthcare workers and 86.3% in the general population. At the other end of the spectrum, hesitancy reached 60.8% in healthcare workers and 50% in the general population. Those extremes point to an important reality: local context could push attitudes sharply in either direction, even within the same country and during the same broad pandemic era.
The pooled estimates were more restrained. Vaccine acceptance was 66.1% among the general population, with a 95% confidence interval of 53% to 78%, and 65.9% among healthcare workers, with a 95% confidence interval of 57% to 74%. The pooled prevalence of vaccine hesitancy was 33% in the general population, with a 95% confidence interval of 20% to 46%, and 24% among healthcare workers, with a 95% confidence interval of 11% to 40%.
One number stands out immediately: the pooled acceptance estimates in healthcare workers and the general population were almost identical. The occupational group expected to be most aligned with vaccination policy did not separate cleanly from the public at large, which suggests that professional knowledge alone did not eliminate uncertainty, fear, or mistrust.
Heterogeneity Was So High It Demands Caution
The most important statistical finding was not the pooled estimate itself. It was the degree of heterogeneity.
Acceptance showed I² greater than 99%, and hesitancy showed I² greater than 98%. In practical terms, those values indicate extreme between-study variation that cannot be explained by chance alone. Such dispersion weakens any attempt to apply one pooled percentage uniformly across India’s diverse settings. It also warns against overreading the pooled point estimate as if it represented a stable national average.
Several plausible drivers sit behind that spread. Differences in study design, participant demographics, timing relative to vaccine rollout, exposure to misinformation, local disease burden, and institutional trust can all shift willingness sharply. A survey conducted early in vaccine deployment may capture uncertainty that disappears after more people are vaccinated safely. A survey in a healthcare setting may reflect different concerns from one done in a rural community or among pregnant women.
Why the Findings Matter for Public Health Strategy
COVID-19 vaccination campaigns depend on more than supply chains and cold storage. They also depend on the psychology of risk. When acceptance is inconsistent, public health programs need messaging that addresses safety concerns, perceived necessity, and trust in the system rather than assuming uniform buy-in.
These findings suggest that India’s vaccination strategy cannot rely on a single communication model. Healthcare workers may need targeted interventions that address professional skepticism, workload pressures, and evolving evidence. Community campaigns may need locally tailored outreach that accounts for literacy, access to care, and information quality. For pregnant women and other subgroups, safety concerns may be more intense and require direct counseling rooted in clinical evidence and consistent messaging from trusted providers.
The pooled figures also hint at a broader behavioral problem in infectious disease control. Even when vaccines are available, uptake is not automatic. Public health success depends on how a population interprets risk, how much confidence it places in institutions, and how clearly benefits are communicated across different social settings.
Interpretation Must Stay Within the Limits of the Evidence
The review offers a useful map of Indian vaccine attitudes, but it does not provide a single clean national answer. Cross-sectional studies can estimate prevalence, yet they cannot show how attitudes change over time in the same individuals or determine which interventions most effectively reduce hesitancy. The wide spread in results also means the pooled estimates should be read as broad approximations rather than precise national constants.
The authors’ closing message is straightforward: future research needs stronger comparability and better generalizability. Study timing, sampling methods, regional context, and participant mix all appear capable of shifting acceptance and hesitancy estimates. Without more consistent methods, direct comparisons across Indian studies will remain difficult, and the true drivers of hesitancy may stay blurred behind statistical noise.
For clinicians and public health planners, the most actionable lesson is the one embedded in the heterogeneity itself. Acceptance of COVID-19 vaccination in India was neither uniformly high nor uniformly low; it moved according to who was asked, when they were asked, and where they lived or worked. A vaccination campaign that ignores that variability risks speaking too broadly to a population that responds in highly local, highly specific ways.